Chronic inflammatory demyelinating polyradiculoneuropathies ( CIDP ) with monotruncular onset: Frequency, clinical features, electrophysiology, and evolution
European Journal of Neurology · 2025
DOI: 10.1111/ene.16560 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Julie Pascaud und 8 weiteren Autor:innen. Beteiligte Einrichtung: Referral Centre for Neuromuscular Diseases and ALS, Hospital La Timone, Aix-Marseille University, Marseille, France. Hauptthemen laut MEDLINE: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Neural Conduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Multifocal chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the most frequent variant of CIDP. It is characterized by asymmetric multifocal sensory and motor impairments. Few cases with monotruncular onset have been described. The aim of the study was to characterize the clinical, electrophysiological, and radiological features of these monotruncular‐onset CIDP cases.
Methods
The records of 145 patients with focal/multifocal CIDP followed in the hospital department revealed 16 patients with an initial clinical involvement limited to one nerve for at least 6 months.
Results
Median diagnostic delay was 24 months. The ulnar nerve was the most frequently involved nerve (44%, 7/16). Based on extensive electrodiagnostic testing at initial evaluation, 5 patients (31%) met the electrodiagnostic criteria for CIDP and 8 patients (50%) for possible CIDP. Conduction blocks (CB) were the most frequent conduction abnormalities. Motor evoked potentials using a triple‐stimulation technique showed proximal CB in 12/13 patients. Plexus magnetic resonance imaging was abnormal in 13/15 patients (86%), with bilateral short tau inversion recovery (STIR)‐hypersignal in 7 patients. Intravenous immunoglobulins (IVIg) were efficient for 12/15 patients (80%). During follow‐up (median 8 years), 3 patients retained monotruncular involvement while 13 had a multitruncular worsening. The only difference was that IVIg treatment was started earlier in patients who were still monotruncular at the last visit (11 vs. 87 months, p = 0.015).
Conclusions
Monotruncular onset occurred in 11% of the focal/multifocal CIDP cases. Supportive criteria are highly valuable for positive diagnosis of this condition. The natural course tends to be progressive, involving more nerve trunks. Early treatment may prevent the disease from spreading.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Referral Centre for Neuromuscular Diseases and ALS, Hospital La Timone, Aix-Marseille University, Marseille, France.
ORCID-Profile: Annie Verschueren, Aude-Marie Grapperon, Emilien Delmont
Zitieren
APA
Pascaud, J., Fortanier, E., Salort-Campana, E., Verschueren, A., Keriel, P., Grapperon, A. M., Kouton, L., Attarian, S., & Delmont, E. (2025). Chronic inflammatory demyelinating polyradiculoneuropathies ( CIDP ) with monotruncular onset: Frequency, clinical features, electrophysiology, and evolution. European Journal of Neurology. https://doi.org/10.1111/ene.16560
Vancouver
Pascaud J, Fortanier E, Salort-Campana E, Verschueren A, Keriel P, Grapperon AM, et al. Chronic inflammatory demyelinating polyradiculoneuropathies ( CIDP ) with monotruncular onset: Frequency, clinical features, electrophysiology, and evolution. European Journal of Neurology. 2025. doi:10.1111/ene.16560
BibTeX
@article{Pascaud2025,
author = {Pascaud, Julie and Fortanier, Etienne and Salort-Campana, Emmanuelle and Verschueren, Annie and Keriel, Pierrick and Grapperon, Aude-Marie and Kouton, Ludivine and Attarian, Shahram and Delmont, Emilien},
title = {Chronic inflammatory demyelinating polyradiculoneuropathies ( CIDP ) with monotruncular onset: Frequency, clinical features, electrophysiology, and evolution},
journal = {European Journal of Neurology},
year = {2025},
doi = {10.1111/ene.16560}
}
EUVIMED